Literature DB >> 10640524

Analysis of chromosome loss and chromosome segregation in cytokinesis-blocked human lymphocytes: non-disjunction is the prevalent mistake in chromosome segregation produced by low dose exposure to ionizing radiation.

N Touil1, A Elhajouji, H Thierens, M Kirsch-Volders.   

Abstract

The aim of the present work was to examine in human lymphocytes, firstly, whether in vitro gamma-rays as compared with X-rays also induce chromatid malsegregation and at higher frequencies than chromosome loss and, secondly, whether the cytokinesis-blocked micronucleus assay combined with fluorescence in situ hybridization might be useful for the biomonitoring of individuals exposed to ionizing radiation. After irradiation, the relative frequencies of centromere-positive micronuclei decreased from 39.2% at 0.1 Gy to 21. 63% at higher doses. There was no statistically significant increase in MNCen+ frequencies at doses below 1 Gy (0.1, 0.25 and 0.5 Gy), but a statistically significant increase at 1 (P < 0.05) and 2 Gy (P < 0.001) was observed for all the donors. No significant differences in baseline and gamma-ray-induced non-disjunction frequencies for chromosomes 1 (P = 0.9) and 17 (P = 0.8) between individuals were detected. For radiation-induced non-disjunction, lower doses (0.1, 0. 25 and 0.5 Gy) of gamma-rays did not induce a statistically significant increase in non-disjunction frequencies whereas 1 Gy and above clearly induced a statistically significant increase in the total non-disjunction frequencies for all the donors (P < 0.05 at 1 Gy and P < 0.0001 at 2 Gy). The aneugenic effect of radiation is less clearly dose dependent at the lower doses, suggesting an apparent threshold below which no change could be demonstrated. At high radiation doses the major mechanism for gamma-ray-induced aneuploidy is related to chromosome loss through non-disjunction, as has been demonstrated using X-rays, and not through the formation of micronuclei.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640524     DOI: 10.1093/mutage/15.1.1

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  7 in total

1.  Merotelic attachments and non-homologous end joining are the basis of chromosomal instability.

Authors:  Astrid Alonso Guerrero; Carlos Martínez-A; Karel Hm van Wely
Journal:  Cell Div       Date:  2010-05-17       Impact factor: 5.130

2.  In vitro micronucleus assay scored by flow cytometry provides a comprehensive evaluation of cytogenetic damage and cytotoxicity.

Authors:  Steven M Bryce; Jeffrey C Bemis; Svetlana L Avlasevich; Stephen D Dertinger
Journal:  Mutat Res       Date:  2007-03-19       Impact factor: 2.433

3.  Increased lymphocyte micronucleus frequency in early pregnancy is associated prospectively with pre-eclampsia and/or intrauterine growth restriction.

Authors:  D L F Furness; G A Dekker; W M Hague; T Y Khong; M F Fenech
Journal:  Mutagenesis       Date:  2010-06-25       Impact factor: 3.000

4.  Fluorescence in situ hybridization in combination with the comet assay and micronucleus test in genetic toxicology.

Authors:  Galina G Hovhannisyan
Journal:  Mol Cytogenet       Date:  2010-09-15       Impact factor: 2.009

5.  Generation of an integrated Hieracium genomic and transcriptomic resource enables exploration of small RNA pathways during apomixis initiation.

Authors:  David S Rabiger; Jennifer M Taylor; Andrew Spriggs; Melanie L Hand; Steven T Henderson; Susan D Johnson; Karsten Oelkers; Maria Hrmova; Keisuke Saito; Go Suzuki; Yasuhiko Mukai; Bernard J Carroll; Anna M G Koltunow
Journal:  BMC Biol       Date:  2016-10-06       Impact factor: 7.431

6.  X-ray Ptychography Imaging of Human Chromosomes After Low-dose Irradiation.

Authors:  Archana Bhartiya; Darren Batey; Silvia Cipiccia; Xiaowen Shi; Christoph Rau; Stanley Botchway; Mohammed Yusuf; Ian K Robinson
Journal:  Chromosome Res       Date:  2021-03-31       Impact factor: 5.239

7.  Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer.

Authors:  Emre Kocakavuk; Kevin J Anderson; Frederick S Varn; Kevin C Johnson; Samirkumar B Amin; Erik P Sulman; Martijn P Lolkema; Floris P Barthel; Roel G W Verhaak
Journal:  Nat Genet       Date:  2021-05-27       Impact factor: 38.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.